IDXX logo

IDXX
Idexx Laboratories Inc

2,951
Mkt Cap
$56.57B
Volume
409,936.00
52W High
$735.00
52W Low
$356.14
PE Ratio
56.16
IDXX Fundamentals
Price
$704.38
Prev Close
$713.74
Open
$710.15
50D MA
$645.28
Beta
1.16
Avg. Volume
435,607.78
EPS (Annual)
$10.67
P/B
36.30
Rev/Employee
$354,318.54
Loading...
Loading...
News
all
press releases
IDEXX Laboratories, Inc. $IDXX Shares Purchased by Achmea Investment Management B.V.
Achmea Investment Management B.V. grew its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 100.1% in the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·21h ago
News Placeholder
More News
News Placeholder
IDEXX Laboratories (NASDAQ:IDXX) Upgraded at Wall Street Zen
Wall Street Zen raised shares of IDEXX Laboratories from a "buy" rating to a "strong-buy" rating in a research note on Saturday...
MarketBeat·22h ago
News Placeholder
Top Water Stocks To Add to Your Watchlist - November 7th
CocaCola, NuScale Power, Ecolab, IDEXX Laboratories, and Texas Pacific Land are the five Water stocks to watch today, according to MarketBeat's stock screener tool. "Water stocks" are shares of...
MarketBeat·1d ago
News Placeholder
Bryn Mawr Trust Advisors LLC Acquires 1,051 Shares of IDEXX Laboratories, Inc. $IDXX
Bryn Mawr Trust Advisors LLC boosted its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 10.3% during the second quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Top Water Stocks To Consider - November 6th
CocaCola, IDEXX Laboratories, NuScale Power, Waters, Advanced Drainage Systems, Texas Pacific Land, and Ecolab are the seven Water stocks to watch today, according to MarketBeat's stock screener...
MarketBeat·2d ago
News Placeholder
Peering Into IDEXX Laboratories Inc's Recent Short Interest
read more...
Benzinga·3d ago
News Placeholder
STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up
STERIS posts strong Q2 results with earnings and revenue beats, margin expansion, and a raised 2026 EPS outlook.
Zacks·3d ago
News Placeholder
Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop
Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.
Zacks·4d ago
News Placeholder
TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours
Tempus AI reports a narrower-than-expected Q3 loss and stronger revenues, raises full-year outlook, but shares decline following the results.
Zacks·4d ago
News Placeholder
TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up
Bio-Techne's Q1 earnings meet expectations, but revenues slip 1%, sending shares lower despite stronger margins.
Zacks·4d ago

Latest IDXX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.